相关实验视频

Updated: May 6, 2026

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

解读高氏病类型1的代谢变化:一个多omics研究

Franklin Ducatez^1,2, Marc G Berger^3,4, Carine Pilon¹

¹Department of Metabolic Biochemistry, Referral Center for Lysosomal Diseases, Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, Filière G2M, 76000, Rouen, France.

Journal of molecular medicine (Berlin, Germany)

|December 31, 2024

概括

氏病 (GD) 涉及改变的脂质代谢和炎症,与线粒体功能障碍的迹象. 自抑制通过mTORC1激活驱动这些问题,影响GD进展.

科学领域:

生物化学生物化学
免疫学免疫学免疫学
遗传学遗传学是一个

背景情况:

氏病 (Gaucher disease,简称GD) 是一种由缺少β-葡萄糖脑酶 (GCase) 引起的自身遗传性 lysosomal 疾病.
这种缺乏导致葡萄糖胺的积累,导致各种临床表现.
了解GD的生化场景对于开发向疗法至关重要.

研究的目的:

综合调查1型高氏病患者的生物化学和免疫特征.
识别新型生物标志物并了解GD病变的基础分子机制.
为了将omics特征与临床特征和治疗状态相关联.

主要方法:

采用了基于免疫的蛋白质组学和基于质谱的代谢组学.
43名1型GD患者和59名对照人群具有深度表型.
传统和系统生物学方法用于数据分析.

主要成果:

酸丁胆含量升高表明脂质代谢发生变化和内质网膜应激.
GD患者表现出炎症特征,细胞因子升高和自身免疫性炎症.
线粒体功能障碍是由氧化应激标志物和改变的乙卡尼丁样本所暗示的.

结论:

通过慢性mTORC1激活来抑制自,是GD的关键,驱动脂质合成,线粒体功能障碍和炎症.
特定的奥米克特征与血小板计数和脊髓切除术等临床特征相关,提供潜在的诊断标记.
这项研究为GD的代谢和免疫失调提供了宝贵的见解,为未来的研究铺平了道路.

关键词:

戈舍氏病是戈舍氏病的一种疾病.遗传代谢性疾病遗传代谢性疾病 Lysosomal 疾病是一种溶解体疾病.俄米克斯 (Omics) 是一个电子游戏.系统生物学系统生物学

更多相关视频

The MPLEx Protocol for Multi-omic Analyses of Soil Samples

The MPLEx Protocol for Multi-omic Analyses of Soil Samples

Published on: May 30, 2018

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

相关概念视频

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...